Arrowhead Research | ARWR - Activos Circulantes





Activos Circulantes Cambio Fecha
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Anika Therapeutics USD 93.56M 9.8M 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Ligand Pharmaceuticals USD 865.42M 33.14M 2026-03
Merck USD 35.02B 8.5B 2026-03
Moderna USD 5.77B 774M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
TG Therapeutics USD 1.09B 456.2M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xencor USD 482.85M 116.97M 2026-03